# Investigation of a Long-Acting Follicle Stimulating Hormone in Infertile Women Undergoing Assisted Reproductive Technology (ART)

> **NCT00505752** · PHASE2 · COMPLETED · sponsor: **Merck KGaA, Darmstadt, Germany** · enrollment: 520 (actual)

## Conditions studied

- Infertility

## Interventions

- **DRUG:** AS900672-Enriched 50 microgram (mcg)
- **DRUG:** AS900672-Enriched 100 mcg
- **DRUG:** AS900672-Enriched 150 mcg
- **DRUG:** Follitropin alfa 150 international unit (IU)
- **DRUG:** Recombinant human chorionic gonadotropin (r-hCG)

## Key facts

- **NCT ID:** NCT00505752
- **Lead sponsor:** Merck KGaA, Darmstadt, Germany
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 520 (ACTUAL)
- **Last updated:** 2014-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00505752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00505752, "Investigation of a Long-Acting Follicle Stimulating Hormone in Infertile Women Undergoing Assisted Reproductive Technology (ART)". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00505752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*